Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Blake A. Jacobson"'
Publikováno v:
Translational Oncology, Vol 13, Iss 7, Pp 100782- (2020)
Oncolytic viruses have demonstrated efficacy in numerous tumor models including non-small cell lung cancer (NSCLC). One limitation of viral therapy for metastatic lung cancer is that systemic administration can be hindered by complement and antiviral
Externí odkaz:
https://doaj.org/article/b8a08c9a21bb4526bddc77af94aecb4d
Autor:
Manish R. Patel, Carston R. Wagner, Sierra Chen, Nicolas Vattendahl Vidal, Aniekan Okon, Gabriel W. Vattendahl Vidal, Blake A. Jacobson, Zeeshan Ahmad, Mitchell W. McDonald, Robert A. Kratzke, Maxwell Dillenburg
Publikováno v:
Cancer Chemotherapy and Pharmacology. 85:425-432
Activated cap-dependent translation promotes cancer by stimulating translation of mRNAs encoding malignancy-promoting proteins. The nucleoside monophosphate Protide, 4Ei-10, undergoes intracellular uptake and conversion by Hint1 to form 7-Cl-Ph-Ethyl
Autor:
Alexander S. Dash, Blake A. Jacobson, Robert A. Kratzke, Manish R. Patel, Kareem A. Ismail, Yan Ji, Daniel Baumann
Publikováno v:
Cancer Gene Therapy. 26:411-418
The concept of using viruses to treat cancer has now shown proof of concept in several recent clinical trials, leading to the first FDA approval of virotherapy for melanoma last year. Vesicular stomatitis virus (VSV) is a promising oncolytic virus th
Publikováno v:
The FASEB Journal. 35
Autor:
Daniel A. Cambron, Manish R. Patel, Anil J. Patel, Blake A. Jacobson, Emilia Stoian, Maxwell Dillenburg, Zeeshan Ahmad, Robert A. Kratzke, Carston R. Wagner, Sierra Chen, Gabriella Waldusky
Publikováno v:
Investigational new drugs. 39(3)
In order to suppress 5' cap-mediated translation a highly available inhibitor of the interaction between the 5' mRNA cap and the eIF4E complex has been developed. 4Ei-10 is a member of the class of ProTide compounds and has elevated membrane permeabi
Publikováno v:
Translational Oncology, Vol 13, Iss 7, Pp 100782-(2020)
Translational Oncology
Translational Oncology
Oncolytic viruses have demonstrated efficacy in numerous tumor models including non-small cell lung cancer (NSCLC). One limitation of viral therapy for metastatic lung cancer is that systemic administration can be hindered by complement and antiviral
Autor:
Robert A. Kratzke, Marian G. Kratzke, Arpita De, Blake A. Jacobson, Joe Jay-Dixon, Manish R. Patel, Mark S. Peterson, Ahad A. Sadiq
Publikováno v:
Investigational New Drugs. 36:217-229
Deregulation of cap-dependent translation has been implicated in the malignant transformation of numerous human tissues. 4EGI-1, a novel small-molecule inhibitor of cap-dependent translation, disrupts formation of the eukaryotic initiation factor 4F
Autor:
Robert A. Kratzke, Joe Jay-Dixon, Jeremy Drees, Ahad A. Sadiq, Stephen J. Russell, Manish R. Patel, Blake A. Jacobson, Shaogeng Tang, Brent S. Sorenson
Publikováno v:
Oncotarget
Malignant mesothelioma has a poor prognosis for which there remains an urgent need for successful treatment approaches. Infection with the Edmonston vaccine strain (MV-Edm) derivative of measles virus results in lysis of cancer cells and has been tes
Autor:
Zeeshan, Ahmad, Blake A, Jacobson, Mitchell W, McDonald, Nicolas, Vattendahl Vidal, Gabriel, Vattendahl Vidal, Sierra, Chen, Maxwell, Dillenburg, Aniekan M, Okon, Manish R, Patel, Carston R, Wagner, Robert A, Kratzke
Publikováno v:
Cancer chemotherapy and pharmacology. 85(2)
Activated cap-dependent translation promotes cancer by stimulating translation of mRNAs encoding malignancy-promoting proteins. The nucleoside monophosphate Protide, 4Ei-10, undergoes intracellular uptake and conversion by Hint1 to form 7-Cl-Ph-Ethyl
Publikováno v:
The FASEB Journal. 34:1-1